- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Franklin Today
By the People, for the People
Franklin Street Advisors Inc. NC Invests in Axsome Therapeutics
The institutional investor acquired 10,000 shares of the pharmaceutical company's stock.
Apr. 9, 2026 at 8:24am
Got story updates? Submit your updates here. ›
An institutional investor's new position in a pharmaceutical company reflects growing confidence in the firm's central nervous system drug pipeline.Franklin TodayFranklin Street Advisors Inc. NC, an institutional investor, acquired a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) during the fourth quarter. The firm purchased 10,000 shares of the company's stock, valued at approximately $1,826,000.
Why it matters
Axsome Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. The investment by Franklin Street Advisors Inc. NC suggests institutional confidence in the company's pipeline and future growth potential.
The details
According to a disclosure with the Securities and Exchange Commission, Franklin Street Advisors Inc. NC was one of several institutional investors that added to or reduced their stakes in Axsome Therapeutics during the fourth quarter. Other major investors that increased their positions include Wellington Management Group LLP, Invesco Ltd., and Adage Capital Partners GP L.L.C.
- Franklin Street Advisors Inc. NC acquired the new position in Axsome Therapeutics during the fourth quarter of 2025.
The players
Franklin Street Advisors Inc. NC
An institutional investor that acquired a new position in Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
A clinical-stage biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders.
The takeaway
The investment by Franklin Street Advisors Inc. NC in Axsome Therapeutics reflects growing institutional interest in the company's pipeline of CNS drug candidates, which could signal positive momentum for the stock going forward.
